Data as of Friday, October 23, 2026From 500 companies’ SEC filings · refreshed twice a day · Send feedback
Companies / Health Care / Life Sciences Tools & Services

Bio-Techne stock buybacks

TECH
$42Mbought back in the 12 months to Jun 30, 2026

Bio-Techne bought back $42M of its stock in the last twelve months, $310,000 more than it paid out in stock compensation. Its share count is down 0.6% from a year earlier.

Stock repurchases by quarter
$0$60M$120MQ3 '20Q3 '21Q3 '22Q3 '23Q3 '24Q2 '26
Show as table
PeriodValue
Q3 '20$0
Q4 '20$0
Q1 '21$43.2M
Q2 '21$0
Q3 '21$0
Q4 '21$0
Q1 '22$60.8M
Q2 '22$58.8M
Q3 '22$19.6M
Q4 '22$0
Q1 '23$0
Q2 '23$0
Q3 '23$0
Q4 '23$0
Q1 '24$0
Q2 '24$0
Q3 '24$0
Q4 '24$0
Q1 '25$100.0M
Q2 '25$100.1M
Q3 '25$24,000
Q4 '25$0
Q1 '26$0
Q2 '26$41.7M
Diluted shares outstanding
156.7M160.6M164.4MQ3 '20Q3 '21Q3 '22Q3 '23Q3 '24Q3 '25Q2 '26
Show as table
PeriodValue
Q3 '20160.1M
Q4 '20161.0M
Q1 '21162.7M
Q2 '21163.9M
Q3 '21164.6M
Q4 '21164.8M
Q1 '22163.9M
Q2 '22163.1M
Q3 '22162.2M
Q4 '22161.8M
Q1 '23161.6M
Q2 '23161.9M
Q3 '23161.9M
Q4 '23160.1M
Q1 '24160.5M
Q2 '24160.6M
Q3 '24161.1M
Q4 '24160.6M
Q1 '25158.9M
Q2 '25158.2M
Q3 '25156.4M
Q4 '25157.0M
Q1 '26157.4M
Q2 '26157.3M
$42Mlast quarter (Q2 2026)
$310,000net of stock compensation ($41M)
−0.6%diluted shares, 1 year
−3.0%diluted shares, 5 years
$50Mdividends, 12 months
16%of free cash flow ($263M) spent on buybacks
$0raised by issuing stock, 12 months
156.8Mshares outstanding (Aug 17, 2026)

Share counts are adjusted for a stock split (4-for-1).

By fiscal year

Fiscal yearBuybacksDividendsStock payFree cash flowDiluted sharesFiling
2026$42M$50M$41M$263M157.0M10-K
2025$276M$50M$41M$257M159.7M10-K
2024$80M$50M$38M$236M160.8M10-K
2023$20M$50M$39M$216M161.9M10-K
2022$161M$50M$42M$280M164.1M10-K
2021$43M$50M$49M$308M161.9M10-K
2020$50M$49M$32M$153M157.6M10-K
2019$15M$48M$32M$156M155.6M10-K
2018$0$48M$28M$149M152.2M10-K
2015$0$47M$6M—148.9M10-K

Questions

Does Bio-Techne buy back its stock?
Bio-Techne bought back $42M of its stock in the last twelve months, $310,000 more than it paid out in stock compensation. Its share count is down 0.6% from a year earlier.
How much did Bio-Techne spend on buybacks in fiscal 2026?
$42M, according to its 10-K for the fiscal year ending Jun 30, 2026.
Is Bio-Techne's share count going down?
Its diluted share count changed −3.0% over five fiscal years and −0.6% over the last year.

Latest filing used: 10-K for the period ending Jun 30, 2026, filed Aug 24, 2026 · open on SEC.gov

Other Health Care companies